📰 Treat Type News
Treat Type News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Treat Type. Real-time updates on events, politics, business and more.
September 7, 2023
Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.
May 3, 2023
Should you be adding turmeric to your diet when suffering from high blood sugar? Let's find out the answer. TheHealthSite.com
March 30, 2023
This feature articles commemorates the 10-year anniversary of the FDA's first approval of an SGLT2 inhibitor on March 29, 2013 and provides a snapshot at the class's ascent into the treatment algorithms and guidelines for type 2 diabetes, heart failure, and chronic kidney disease.
March 25, 2023
CBD oil works with the body's endocannabinoid system (ECS). This psychological network is responsible for maintaining normal human health.
December 21, 2022
Cancer has a major impact on society in the United States and worldwide. Cancer statistics describe what happens in large groups of people and provide a...
December 16, 2022
Data Bridge Market Research has recently published a Report, titled, "Lipids Market" The report offers an extensive analysis of key growth strategies, drivers,
December 15, 2022
20 UNSW academics receive NHMRC Ideas Grants for research in medicine and health, and science.
December 1, 2022
"Ready to Use Disinfectant in Personal Use Market" is the title of a new report from Data Bridge Market Research. Key growth strategies, drivers, opportunities,
October 14, 2022
The increasing prevalence of vascular disorders, obesity, diabetes, and osteoarthritis contributed to an increase in amputation incidences, which in turn...
August 30, 2022
The interleukin-4 receptor (IL-4R) is emerging as a potential drug target, projected to potentially be worth up to 10 billion USD. In this article, ACROBiosystems discusses why it is such an attractive drug target and what this could entail.